Severe hospital-acquired pneumonia: A review for clinicians

Current Infectious Disease Reports

Volumn 11, Issue 5, 2009, Pages 349-356

  Dallas, John ^a   Kollef, Marin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PLACEBO; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BACTERIAL VIRULENCE; BIOFILM; CANDIDA; CLINICAL TRIAL; COATED ENDOTRACHEAL TUBE; CONTINUOUS ASPIRATION OF SUBGLOTTIC SECRETION; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG WITHDRAWAL; ENDOTRACHEAL TUBE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG ASPIRATION; LUNG INFILTRATE; MORTALITY; PATHOGENESIS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; REVIEW; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TISSUE CULTURE; TRACHEOBRONCHITIS; TRACHEOSTOMY; TREATMENT DURATION; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS;

EID: 69249100577     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0050-2     Document Type: Review

References (51)

1. American Thoracic Society and Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
2. Anand N, Kollef MH: The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP, and VAP. Semin Respir Crit Care Med 2009, 30:3-9.
3. Gastmeier P, Sohr D, Geffers C, et al.: Risk factors for death due to nosocomial infection in intensive care unit patients: Findings from the Krankenhaus Infektions Surveillance System. Infect Control Hosp Epidemiol 2007, 28:466-472.
4. Venditti M, Falcone M, Corrao S, et al.: Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009, 150:19-26.
5. Ramirez P, Ferrer M, Torres A: Prevention measures for ventilator-associated pneumonia: A new focus on the endotracheal tube. Curr Opin Infect Dis 2007, 20:190-197.
6. Pneumatikos IA, Dragoumanis CK, Bouros DE: Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. Anesthesiology 2009, 110:673-680.
7. Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135-138.
8. Safdar N, Dezfulian C, Collard HR, et al.: Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005, 33:2184-2193.
9. Weber DJ, Rutala WA, Sickbert-Bennett EE, et al.: Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007, 28:825-831.
10. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
11. Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN): Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the NHSN at CDC, 2006-2007. Available at http://www.cdc.gov/nhsn/ dataStat.html. Accessed June 2009.
12. Walkey AJ, Reardon CC, Sulis CA, et al.: Epidemiology of ventilator-associated pneumonia in a long-term acute care hospital. Infect Control Hosp Epidemiol 2009, 30:319-324.
13. Luyt CE, Combes A, Nieszkowska A, et al.: Viral infections in the ICU. Curr Opin Crit Care 2008, 14:605-608.
14. Vincent A, La Scola B, Forel JM, et al.: Clinical significance of a positive serology for mimivirus in patients presenting a suspicion of ventilator-associated pneumonia. Crit Care Med 2009, 37:111-118.
15. Delisle MS, Williamson DR, Perreault MM, et al.: The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 2008, 23:11-17.
16. Roux D, Gaudry S, Dreyfuss D, et al.: Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med 2009, 37:1062-1067.
17. Nseir S, Jozefowicz E, Cavestri B, et al.: Impact of antifungal treatment on Candida-Pseudomonas interaction: A preliminary retrospective case-control study. Intensive Care Med 2007, 33:137-142.
18. Morris AC, Kefala K, Simpson AJ, et al.: Evaluation of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009, 64:516-522.
19. Kollef MH, Kollef KE: Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 2005, 128:2706-2713.
20. Rosbolt MB, Sterling ES, Fahy BG: The utility of the clinical pulmonary infection score. J Intensive Care Med 2009, 24:26-34.
21. Rea-Neto A, Youssef NC, Tuche F, et al.: Diagnosis of ventilator-associated pneumonia: A systematic review of the literature. Crit Care 2008, 12:R56.
22. Christ-Crain M, Stolz D, Bingisser R, et al.: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006, 174:84-93.
23. Nachtigall I, Tamarkin A, Tafelski S, et al.: Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med 2009, 37:159-166.
24. Torres A, Ewig S, Lode H, et al.: Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009, 35:9-29.
25. Song JH; Asian Hospital Acquired Pneumonia Working Group: Treatment recommendations of hospital-acquired pneumonia in Asian countries: First consensus report by the Asian HAP Working Group. Am J Infect Control 2008, 36(4 Suppl):S83-S92.
26. Masterton RG, Galloway A, French G, et al.: Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008, 62:5-34.
27. Muscedere J, Dodek P, Keenan S, et al.: Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment. J Crit Care 2008, 23:138-147.
28. Beardsley JR, Williamson JC, Johnson JW, et al.: Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006, 130:787-793.
29. Kollef KE, Schramm GE, Wills AR, et al.: Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008, 134:281-287.
30. Dennesen PJ, van der Ven AJ, Kessels AG, et al.: Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001, 163:1371-1375.
31. Chastre J, Wolff M, Fagon JY, et al.: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003, 290:2588-2598.
32. Micek ST, Ward S, Fraser VJ, et al.: A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004, 125:1791-1799.
33. Nseir S, Deplanque X, Di Pompeo C, et al.: Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: A case-control study. J Infect 2008, 56:319-325.
34. Joffe AR, Muscedere J, Marshall JC, et al.: The safety of targeted antibiotic therapy for ventilator-associated pneumonia: A multicenter observational study. J Crit Care 2008, 23:82-90.
35. Roberts JA, Lipman J, Blot S, et al.: Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr Opin Crit Care 2008, 14:390-396.
36. Hallal A, Cohn SM, Namias N, et al.: Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: A pilot study. Surg Infect (Larchmt) 2007, 8:73-82.
37. Michalopoulos A, Fotakis D, Virtzili S, et al.: Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study. Respir Med 2008, 102:407-412.
38. Palmer LB, Smaldone GC, Chen JJ, et al.: Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008, 36:2008-2013.
39. Muscedere J, Dodek P, Keenan S, et al.: Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008, 23:126-137.
40. Coffin SE, Klompas M, Classen D, et al.: Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S31-S40.
41. de Smet AM, Kluytmans JA, Cooper BS, et al.: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360:20-31.
42. Dezfulian C, Shojania K, Collard HR, et al.: Subglottic secretion drainage for preventing ventilator-associated pneumonia: A meta-analysis. Am J Med 2005, 118:11-18.
43. Bouza E, Perez MJ, Munoz P, et al.: Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest 2008, 134:938-946.
44. Kollef MH, Afessa B, Anzueto A, et al.: Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: The NASCENT randomized trial. JAMA 2008, 300:805-813.
45. Craven DE, Chroneou A, Zias N, et al.: Ventilator-associated tracheobronchitis: The impact of targeted antibiotic therapy on patient outcomes. Chest 2009, 135:521-528.
46. Nseir S, Favory R, Jozefowicz E, et al.: Antimicrobial treatment for ventilator-associated tracheobronchitis: A randomized, controlled, multicenter study. Crit Care 2008, 12:R62.
47. Griffiths J, Barber VS, Morgan L, et al.: Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ 2005, 330:1243.
48. Blot F, Similowski T, Trouillet JL, et al.: Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients. Intensive Care Med 2008, 34:1779-1787.
49. Nseir S, Di Pompeo C, Jozefowicz E, et al.: Relationship between tracheotomy and ventilator-associated pneumonia: A case control study. Eur Respir J 2007, 30:314-320.
50. Wip C, Napolitano L: Bundles to prevent ventilator-associated pneumonia: how valuable are they? Curr Opin Infect Dis 2009, 22:159-166.
51. Krein SL, Kowalski CP, Damschroder L, et al.: Preventing ventilator-associated pneumonia in the United States: A multicenter mixed-methods study. Infect Control Hosp Epidemiol 2008, 29:933-940.